Identifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C13H11N3OS |
Molar mass | 257.31 gยทmol |
3D model (JSmol) | |
SMILES
| |
InChI
|
M62812 is a drug which acts as a potent and selective antagonist of toll-like receptor 4 (TLR4). In animal studies it blocks TLR4-mediated cytokine release and has antiinflammatory effects, showing efficacy in animal models of arthritis and septic shock.
See also
References
- Nakamura M, Shimizu Y, Sato Y, Miyazaki Y, Satoh T, Mizuno M, et al. (August 2007). "Toll-like receptor 4 signal transduction inhibitor, M62812, suppresses endothelial cell and leukocyte activation and prevents lethal septic shock in mice". European Journal of Pharmacology. 569 (3): 237โ43. doi:10.1016/j.ejphar.2007.05.013. PMID 17588563.
- Park H, Hong J, Yin Y, Joo Y, Kim Y, Shin J, et al. (October 2020). "TAP2, a peptide antagonist of Toll-like receptor 4, attenuates pain and cartilage degradation in a monoiodoacetate-induced arthritis rat model". Scientific Reports. 10 (1): 17451. Bibcode:2020NatSR..1017451P. doi:10.1038/s41598-020-74544-5. PMC 7567100. PMID 33060735.
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |